is an investment and financial services company specialising in Investment Banking, Corporate Advisory and Share Trading services for Australian corporate and private clients, and overseas corporate clients.

  • Address: Level 11, Plaza Building Australia Square, 95 Pitt Street, Sydney, NSW 2000 Australia
  • Phone: +61 2 9375 0100
  • Email: Contact Us
Advent Health Limited (AH1)

Advent Health Limited (AH1)

Advent Health Prospectus May 2020 Advent Health Prospectus May 2020 (3799 KB)

About Advent Heath (ASX:AH1) -  Offer Now  Closed

Advent Health has consolidated 12 multi disciplinary allied health practice groups from a highly fragmented industry into a sustainable business that maintains and enhances profitability and clinical outcomes. The group will provide support to individual practices to allow them to focus on their patients while being able to retain their individual branding.


  • 12 Allied Health Groups comprising 59 clinics across Australia.
  • Businesses comprise of the following disciplines Physiotherapy, Chiropractic, Podiatry,Psychology, Sports Fitness, Mental Health ,Exercise Fitness, Women's Health, and Rehabilitation Services.
  • Audited FY 19 Revenue $35 m with $9.3 m of EBITDA.
  • Average purchase price of ~5x Historic EBITDA – Payable 60-70% in cash and at least 30% in Advent shares (escrowed for 24 months)
  • Management have extensive experience in the industry
  • Strong pipeline of potential future acquisitions
  • Very Competitive pricing on IPO to existing ASX listed entities.
  • Dual track strategy: Growth and Yield. Growth - organically & via acquisition, Yield through regular dividends
  • Offer Open: May 25. Expected Close: June 26 Expected Re-admission and trading on the ASX: Mid July
  • Note: Directors reserve the right to extend or close the offer early

Click here to view the Prospectus and Apply Online

COVID-19 Update

While the businesses have been affected by the COVID-19 lock-downs, none have closed. The overall Advent group performance saw a low point of 30% reduction in weekly revenue around mid April (coinciding with Easter, so seasonally adjusted this is equivalent to 20%). Since then (mid April) revenue has been picking up and is currently (as at May 25) running about 10% below trend. Management expects a return to normal revenues soon.

For further information, please contact Gavan Farley of Novus Capital Limited on Direct +61 2 9375 0114 mobile +61 420 520 300 or via email gavan.farley@novuscapital.com.au

Click here to view the Prospectus and Apply Online